Skip to main content
All ETFs
Watch Compare

FHCQX

ETF
FHCQX · UNKNOWN · 110 holdings

Quick Summary

Price History

Concentration Risk

40,08% Top-heavy
Low risk High risk

The top 10 holdings account for 40,08%. The biggest positions move the needle, but there's enough spread to cushion a single-stock blowup.

Top Holdings Today

Weighted by position size
BSX
▼ -1,84%
LLY
▼ -0,11%
DHR
▼ -2,20%
PEN
▼ -0,29%
ARGX
▼ -1,49%
ALNY
▼ -3,98%
MASI
▼ -0,06%
CVS
▲ 2,40%
ASND
▲ 0,51%
Weighted avg. of top holdings ▼ -0,97%

Sector Allocation

Healthcare
84,48%
Technology
0,89%
Manufacturing
0,86%

Top 10 Holdings

40,08% of fund
BSX BOSTON SCIENTIFIC CORP
6,47%
LLY ELI LILLY and CO
6,45%
DHR DANAHER CORP
6,25%
PEN PENUMBRA INC
4,39%
ARGX ARGENX SE
3,47%
ALNY ALNYLAM PHARMACEUTICALS INC
2,74%
MASI MASIMO CORP
2,67%
UCB SA UCB SA
2,66%
CVS CVS HEALTH CORP
2,63%
ASND ASCENDIS PHARMA A/S
2,35%
Other positions
1,63%

All Holdings (110)

Top 10: 40,08% of fund
# Ticker Name Weight Shares Market Value
1 BSX BOSTON SCIENTIFIC CORP 6,47% 4,25 M 431,72 M
2 LLY ELI LILLY and CO 6,45% 400.000 430,19 M
3 DHR DANAHER CORP 6,25% 1,84 M 417,28 M
4 PEN PENUMBRA INC 4,39% 1,00 M 293,17 M
5 ARGX ARGENX SE 3,47% 254.000 231,64 M
6 ALNY ALNYLAM PHARMACEUTICALS INC 2,74% 405.000 182,75 M
7 MASI MASIMO CORP 2,67% 1,25 M 178,04 M
8 UCB SA UCB SA 2,66% 635.000 177,21 M
9 CVS CVS HEALTH CORP 2,63% 2,18 M 175,18 M
10 ASND ASCENDIS PHARMA A/S 2,35% 740.000 157,12 M
Showing top 10 of 110 holdings · Listed: 98,37% · 1,63% in other positions

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) N/A
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: N/A
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value N/A

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: N/A · EV/EBITDA: N/A
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A

Per Share

EPS: N/A · FCF/Share: N/A
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: N/A · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Sectorvergelijking

vs ETF sector mediaan (25157 peers)
Metriek Aandeel Sector Mediaan
P/E
P/B
ROE %
Net Margin %
Rev Growth 5Y %
D/E